THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

MGH parent curbs fees to staff from drug makers

By Liz Kowalczyk
Globe Staff / January 3, 2010

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size – +

High-ranking physicians and executives at Partners HealthCare, which includes Massachusetts General and Brigham and Women’s hospitals, can no longer receive stock or unlimited fees for sitting on the boards of biotechnology and pharmaceutical companies, under new rules that took effect Friday. (Full article: 586 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass